Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models. [electronic resource]
Producer: 20130801Description: 1011-9 p. digitalISSN:- 1432-0851
- Animals
- Antibodies, Monoclonal -- immunology
- Antibody-Dependent Cell Cytotoxicity -- immunology
- Antigens, Neoplasm -- immunology
- Antineoplastic Agents -- immunology
- Cell Line, Tumor
- Colorectal Neoplasms -- drug therapy
- Disease Models, Animal
- Female
- Humans
- Male
- Mice
- Mucin 5AC -- immunology
- Neoplasms -- drug therapy
- Pancreatic Neoplasms -- drug therapy
- Protein Binding -- immunology
- Recombinant Fusion Proteins
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.